Dazmegrel

Dazmegrel (UK-38485) is a thromboxane synthetase inhibitor which inhibits Thromboxane A2 (TXA2) synthesis and exhibits antiplatelet vasodilator effects. Dazmegrel can be utilized in thrombosis research[1].

Product Specifications

CAS Number

[76894-77-4]

Product Name Alternative

UK38485

UNSPSC

12352005

Target

Prostaglandin Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/dazmegrel.html

Smiles

O=C(CCN1C2=C(C(CN3C=NC=C3)=C1C)C=CC=C2)O

Molecular Formula

C16H17N3O2

Molecular Weight

283.33

References & Citations

[1]Belch JJ, et al. Platelet changes after a saturated fat meal and their prevention by Dazmegrel, a thromboxane synthetase inhibitor. Lipids. 1987 Mar;22 (3) :159-62.